Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAmortization - GoodwillCost of RevenueEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares Issued
Ratios

Integra Lifesciences Holdings (IART) Shares Issued (2016 - 2025)

Integra Lifesciences Holdings (IART) has disclosed Shares Issued for 17 consecutive years, with $957000.0 as the latest value for Q1 2025.

  • Quarterly Shares Issued fell 85.04% to $957000.0 in Q1 2025 from the year-ago period, while the trailing twelve-month figure was $957000.0 through Dec 2025, down 85.04% year-over-year, with the annual reading at $957000.0 for FY2025, 85.04% down from the prior year.
  • Shares Issued hit $957000.0 in Q1 2025 for Integra Lifesciences Holdings, down from $6.4 million in the prior quarter.
  • In the past five years, Shares Issued ranged from a high of $6.4 million in Q1 2024 to a low of $225000.0 in Q4 2023.
  • Historically, Shares Issued has averaged $1.8 million across 5 years, with a median of $1.2 million in 2022.
  • Biggest five-year swings in Shares Issued: surged 1541.1% in 2022 and later tumbled 94.19% in 2023.
  • Year by year, Shares Issued stood at $236000.0 in 2021, then soared by 1541.1% to $3.9 million in 2022, then crashed by 94.19% to $225000.0 in 2023, then skyrocketed by 2743.56% to $6.4 million in 2024, then tumbled by 85.04% to $957000.0 in 2025.
  • Business Quant data shows Shares Issued for IART at $957000.0 in Q1 2025, $6.4 million in Q1 2024, and $225000.0 in Q4 2023.